Related Experiment Video
Updated: Aug 10, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit
Insights
Normal human immunoglobulin effectively protected newborn infants from echovirus 11 infections during an epidemic. This treatment prevented illness in 205 exposed infants, highlighting its value for neonatal care.
Area of Science:
- Virology
- Neonatal Medicine
- Immunology
Background:
- An echovirus 11 epidemic in 1982 affected a special-care baby unit, causing severe illness and death in infants.
- Infections presented with meningitis, respiratory distress, and other serious complications.
Purpose of the Study:
- To evaluate the efficacy of normal human immunoglobulin in preventing echovirus 11 infection in newborn infants.
- To assess the safety and protective action of immunoglobulin against echovirus 11.
Main Methods:
- Intramuscular administration of normal human immunoglobulin (250 mg) containing echovirus 11 antibodies to exposed newborn infants.
- Clinical monitoring for symptoms and ill-effects post-administration.
- Serological studies to confirm antibody presence and protective action.
Main Results:
- None of the 205 infants receiving immunoglobulin immediately after delivery developed symptoms or adverse effects.
- Confirmed infections in 21 infants prior to immunoglobulin administration included fatalities and severe morbidity.
- Serological data supported the protective role of antibodies in immunoglobulin.
Conclusions:
- Normal human immunoglobulin is a valuable prophylactic measure for newborn infants exposed to echovirus 11.
- Early administration of immunoglobulin provides a crucial safeguard against severe outcomes of echovirus 11 infection in neonates.
- The study reinforces the importance of antibody-based interventions in managing neonatal viral epidemics.
Abstract:
An epidemic of echovirus 11 infections occurred in the Cambridge special-care baby unit during August to October, 1982. There were 21 confirmed infections in babies; 1 died, 1 recovered after resection of a kidney, 5 had meningitis, and 6 had respiratory symptoms. Normal human immunoglobulin which contained antibody to echovirus 11 was administered intramuscularly (250 mg) to give protection. None of the children given immunoglobulin immediately after delivery (205 doses) developed symptoms or ill-effects. Serological studies reinforced earlier evidence for the protective action of antibody, and it is considered that immunoglobulin is a valuable safeguard for exposed newborn infants.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Bacterial Meningitis
Bacterial Gastroenteritis
Viral Meningitis
Respiratory Syncytial Virus Disease